Pfizer Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending June 29, 2025: USD 6.79 B

Pfizer Inc. Depreciation And Amortization is USD 6.79 B for the Trailing 12 Months (TTM) ending June 29, 2025, a 1.37% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Pfizer Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 6.70 B, a 16.23% change year over year.
  • Pfizer Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending July 02, 2023 was USD 5.76 B, a 15.26% change year over year.
  • Pfizer Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending July 03, 2022 was USD 5.00 B, a 2.82% change year over year.
  • Pfizer Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending July 04, 2021 was USD 4.86 B, a -10.06% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased